# Big Pharma steps up race for AI-discovered drugs Page: https://stenobird.com/podcast/the-swiss-connection-1071732/big-pharma-steps-up-race-for-ai-discovered-drugs Text version: https://stenobird.com/podcast/the-swiss-connection-1071732/big-pharma-steps-up-race-for-ai-discovered-drugs.md Podcast: [The Swiss Connection](https://stenobird.com/podcast/the-swiss-connection-1071732) Published: 2025-11-18T08:00:00+00:00 Episode link: https://www.buzzsprout.com/910414/episodes/18205011-big-pharma-steps-up-race-for-ai-discovered-drugs.mp3 Audio file: https://www.buzzsprout.com/910414/episodes/18205011-big-pharma-steps-up-race-for-ai-discovered-drugs.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/the-swiss-connection-1071732/episodes/big-pharma-steps-up-race-for-ai-discovered-drugs Duration seconds: 944 ## Resource Send us Fan Mail What if the most valuable drug candidates aren’t found but designed on demand? We follow a chemist’s journey from a pencil-and-paper notebook to generative algorithms that propose novel, IP-free molecules tailored to specific targets, and we open the door to how Swiss pharma is rebuilding discovery around AI. To read more about this topic and for more science stories, visit our website swisinfo.ch. You can help other people to find our podcast by leaving us a five-star revi... ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-swiss-connection-1071732/episodes/big-pharma-steps-up-race-for-ai-discovered-drugs/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/the-swiss-connection-1071732/big-pharma-steps-up-race-for-ai-discovered-drugs.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.